{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T13:45:26Z","timestamp":1648647926889},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00104-005-1100-4","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T14:09:13Z","timestamp":1129730953000},"page":"1145-1154","source":"Crossref","is-referenced-by-count":4,"title":["Prophylaktische Chirurgie des Mamma- und Ovarialkarzinoms"],"prefix":"10.1007","volume":"76","author":[{"given":"M. P.","family":"Lux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Bani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A.","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. W.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1100_CR1","first-page":"385","volume":"52","author":"Beckmann","year":"2001","unstructured":"Beckmann MW, Fasching PA, Lux MP et al. (2001) Das famili\u00e4re Mammakarzinom-Syndrom: pr\u00e4diktive genetische Testung, Beratung und Betreuung. Med Welt 52:385\u2013390","journal-title":"Med Welt"},{"key":"1100_CR2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1055\/s-2004-821050","volume":"64","author":"Fasching","year":"2004","unstructured":"Fasching PA, Lux MP, Bani M, Beckmann MW (2004) Heredit\u00e4res Mamma- und Ovarialkarzinom \u2014 ein Update. Teil I \u2014 molekulare Grundlagen, Tumorrisikoberatung und Risikoberechnung. Geburtsh Frauenheilk 64:900\u2013911","journal-title":"Geburtsh Frauenheilk"},{"key":"1100_CR3","first-page":"review","volume":"cancer","author":"Lux","year":"2005","unstructured":"Lux MP, Fasching PA, Beckmann MW (2005) Hereditary breast and ovarian cancer: review and future perspectives. J Mol Med (in press)","journal-title":"Hereditary breast and ovarian"},{"key":"1100_CR4","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1126\/science.2270482","volume":"250","author":"Hall","year":"1990","unstructured":"Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684\u20131689","journal-title":"Science"},{"key":"1100_CR5","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","volume":"265","author":"Wooster","year":"1994","unstructured":"Wooster R, Neuhausen SL, Mangion J et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12\u201313. Science 265:2088\u20132090","journal-title":"Science"},{"key":"1100_CR6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00761-003-0631-x","volume":"10","author":"Beckmann","year":"2004","unstructured":"Beckmann MW, Lux MP (2004) Heredit\u00e4res Mammakarzinom \u2014 Pr\u00e4diktive Diagnostik und pr\u00e4ventive Chirurgie. Onkologe 10(1):20\u201328","journal-title":"Onkologe"},{"key":"1100_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/bcr448","volume":"4","author":"Easton","year":"2002","unstructured":"Easton DF (2002) Familial risks of breast cancer. Breast Cancer Res 4(5):179\u2013181","journal-title":"Breast Cancer Res"},{"key":"1100_CR8","unstructured":"Easton DF, Breast Cancer Linkage Consortium (2003) Familial breast cancer risks and the BCLC database. The Breast Cancer Linkage Consortium (BCLC) and the International Collaborative Group on Familial Breast and Ovarian Cancer (ICG-FBOC) 14th General Meeting, Madrid, June 2nd\u20134th"},{"key":"1100_CR9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","volume":"359","author":"Haffty","year":"2002","unstructured":"Haffty BG, Harrold E, Khan AJ et al. (2002) Outcome of conservatively managed early-onset breast cancer by BRCA1\/2 status. Lancet 359(9316):1471\u20131477","journal-title":"Lancet"},{"key":"1100_CR10","unstructured":"Boyd J (2001) Molecular genetics of hereditary ovarian cancer. In: Rubin SC, Sutton GP (Hrsg) Ovarian cancer. Vol 2. Lippincott Williams & Wilkins, Philadelphia, S 3\u201317"},{"key":"1100_CR11","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","volume":"91","author":"Breast Cancer Linkage Consortium","year":"1999","unstructured":"Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310\u20131316","journal-title":"J Natl Cancer Inst"},{"key":"1100_CR12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"Thompson","year":"2002","unstructured":"Thompson D, Easton DF, Breast Cancer Linkage Consortium (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"1100_CR13","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1200\/JCO.2002.09.023","volume":"20","author":"Lakhani","year":"2002","unstructured":"Lakhani SR, van de Vijver MJ, Jacqemier J, Anderson TJ, Osin PP, McGuffog L, Easton DF (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, Her-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20:2310\u20132318","journal-title":"J Clin Oncol"},{"key":"1100_CR14","unstructured":"Lakhani SR (2003) The pathology of familial breast cancer. The Breast Cancer Linkage Consortium (BCLC) and the International Collaborative Group on Familial Breast and Ovarian Cancer (ICG-FBOC). 14th General Meeting, Madrid, June 2nd\u20134th"},{"key":"1100_CR15","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","volume":"11","author":"Lakhani","year":"2005","unstructured":"Lakhani SR, Reis-Filho JS, Fulford L et al., Breast Cancer Linkage Consortium (2005) Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype. Clin Cancer Res 11 (14):5175\u20135180","journal-title":"Clin Cancer Res"},{"key":"1100_CR16","first-page":"868","volume":"59","author":"Pharoah","year":"1999","unstructured":"Pharoah PD, Easton DF, Stockton DL, Gayther S, Ponder BA (1999) Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. Cancer Res 59:868\u2013871","journal-title":"Cancer Res"},{"key":"1100_CR17","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/cncr.11310","volume":"97","author":"Cass","year":"2003","unstructured":"Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY (2003) Improved survival in women with BRCA-associated ovarian carcinoma. Cancer 97(9):2187\u20132195","journal-title":"Cancer"},{"key":"1100_CR18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.2002.6646","volume":"85","author":"Levine","year":"2002","unstructured":"Levine DA, Frederici MG, Reuter VE, Boyd J (2002) Cell proliferation and apoptosis in BRCA-associated hereditary ovarian cancer. Gynecol Oncol 85:431\u2013434","journal-title":"Gynecol Oncol"},{"key":"1100_CR19","first-page":"2465","volume":"3","author":"Foulkes","year":"1997","unstructured":"Foulkes WD, Wong N, Brunet JS et al. (1997) Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res 3:2465\u20132469","journal-title":"Clin Cancer Res"},{"key":"1100_CR20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(05)79248-5","volume":"352","author":"Ansquer","year":"1998","unstructured":"Ansquer Y, Gautier C, Fourquet A et al. (1998) Survival in early-onset BRCA1 breast-cancer patients. Lancet 352:541","journal-title":"Lancet"},{"key":"1100_CR21","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/jnci\/91.24.2112","volume":"91","author":"Robson","year":"1999","unstructured":"Robson M, Levin D, Federici M et al. (1999) Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst 91:2112\u20132117","journal-title":"J Natl Cancer Inst"},{"key":"1100_CR22","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1200\/JCO.2000.18.24.4053","volume":"18","author":"Stoppa-Lyonnet","year":"2000","unstructured":"Stoppa-Lyonnet D, Ansquer Y, Dreyfus H et al. (2000) Familial invasive breast cancers: worse outcome related to BRCA1-mutations. J Clin Oncol 18:4053\u20134059","journal-title":"J Clin Oncol"},{"key":"1100_CR23","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra012284","volume":"348","author":"Wooster","year":"2003","unstructured":"Wooster R, Weber BL (2003) Breast and ovarian cancer. N Engl J Med 348:2339\u20132347","journal-title":"N Engl J Med"},{"key":"1100_CR24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnci\/dji141","volume":"97","author":"Thompson","year":"2005","unstructured":"Thompson D, Duedal S, Kirner J et al. (2005) Cancer Risks and Mortality in Heterozygous ATM Mutation Carriers. J Nat Cancer Inst 97(11):813\u2013822","journal-title":"J Nat Cancer Inst"},{"key":"1100_CR25","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.1365-2168.2002.02290.x","volume":"89","author":"Lawes","year":"2002","unstructured":"Lawes DA, SenGupta SB, Boulos PB (2002) Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer. Br J Surg 89(11):1357","journal-title":"Br J Surg"},{"key":"1100_CR26","first-page":"12","volume":"10","author":"Beckmannn","year":"2005","unstructured":"Beckmannn MW, Fasching PA, Bani MR, Lux MP (2005) Clinical hereditary syndromes in gynaecology. Gynaecol Forum 10(1):12\u201317","journal-title":"Gynaecol Forum"},{"key":"1100_CR27","unstructured":"Lux MP, Fasching PA, Bani MR, L\u00f6hberg C, P\u00f6hls U, Ackermann S, Beckmann MW (2003) Prophylaktische Therapieoptionen bei Hereditary non-polyposis colorectal cancer (HNPCC)-assozierten gyn\u00e4kologischen Malignomen. In: Sutter T, Brauckhoff M, Dralle H (Hrsg) Aktuelle Chirurgie endokriner Erkrankungen und heredit\u00e4rer Tumoren. Gutenberg Verlag und Druckerei GmBH, Leipzig, S 1673\u20131691"},{"key":"1100_CR28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ijc.10667","volume":"102","author":"Boks","year":"2002","unstructured":"Boks DES, Trujillo AP, Voogd AC, Morreau H, Kenter GG, Vasen HFA (2002) Survival Analysis of Endometral Carcinoma associated with hereditary Nonpolyposis Colorectal Cancer. Int J Cancer 102:198\u2013200","journal-title":"Int J Cancer"},{"key":"1100_CR29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","volume":"82","author":"Watson","year":"2001","unstructured":"Watson P, B\u00fctzow R, Lynch HAT et al. and the International Collaborative Group on HNPCC (2001) The Clinical Features of Ovarian Cancer in Hereditary Nonpolyposis Colorectal Cancer. Gynecol Oncol 82:223\u2013228","journal-title":"Gynecol Oncol"},{"key":"1100_CR30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jmg.39.4.225","volume":"39","author":"De Jong","year":"2002","unstructured":"De Jong MM, Nolte IM, te Meermann GJ et al. (2002) Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet 39:225\u2013242","journal-title":"J Med Genet"},{"key":"1100_CR31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1055\/s-2004-821085","volume":"64","author":"Lux","year":"2004","unstructured":"Lux MP, Fasching PA, Bani MR, Beckmann MW (2004) Heredit\u00e4res Mamma- und Ovarialkarzinom \u2014 ein Update. Teil II \u2014 Therapie, Fr\u00fcherkennung und Prophylaxe. Geburtsh Frauenheilk 64:1037\u20131051","journal-title":"Geburtsh Frauenheilk"},{"key":"1100_CR32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/jmg.40.11.807","volume":"40","author":"Amir","year":"2003","unstructured":"Amir E, Evans DG, Shenton A et al. (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40:807\u2013814","journal-title":"J Med Genet"},{"key":"1100_CR33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/annonc\/mdg030","volume":"14","author":"Pichert","year":"2003","unstructured":"Pichert G, Bollinger B, Buser K, Pagani O (2003) Evidence-based management for women at increased breast\/ ovarian cancer risk. Ann Oncol 14:9\u201319","journal-title":"Ann Oncol"},{"key":"1100_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01570320","volume":"13","author":"Pennisi","year":"1989","unstructured":"Pennisi VR, Capozzi A (1989) Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg 13:15\u201321","journal-title":"Aesthetic Plast Surg"},{"key":"1100_CR35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE et al. (1999) Efficacy of bilateral prophylactic mastectomy in women with family history of breast cancer. N Engl J Med 340:77\u201384","journal-title":"N Engl J Med"},{"key":"1100_CR36","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ et al. (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633\u20131642","journal-title":"J Natl Cancer Inst"},{"key":"1100_CR37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200107193450301","volume":"345","author":"Meijers-Heiboer","year":"2001","unstructured":"Meijers-Heiboer H, van Geel B, van Puuten WLJ et al. (2001) Breast cancer after prphylactic bliateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159\u2013164","journal-title":"N Engl J Med"},{"key":"1100_CR38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1200\/JCO.2003.02.137","volume":"21","author":"Hoogerbrugge","year":"2003","unstructured":"Hoogerbrugge N, Bult P, de Widt-Levert LM et al. (2003) High Prevalence of Premalignant Lesions in Prophylactically Removed Breasts From Women at Hereditary Risk for Breast Cancer. J Clin Oncol 21 (1):41\u201345","journal-title":"J Clin Oncol"},{"key":"1100_CR39","first-page":"1","volume":"2","author":"Lostumbo","year":"2005","unstructured":"Lostumbo L, Carbine N, Wallace J, Ezzo J (2005) Propyhlactic mastectomy for the prevention of breast cancer. Cochrane Library 2:1\u201358","journal-title":"Cochrane Library"},{"key":"1100_CR40","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/01.PRS.0000153220.66955.39","volume":"115","author":"Spears","year":"2005","unstructured":"Spears SL, Carter ME, Schwarz K (2005) Prophylactic mastectomy: options and reconstructive alternatives. Plast Reconst Surg 115:891\u2013909","journal-title":"Plast Reconst Surg"},{"key":"1100_CR41","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2502::AID-CNCR7>3.0.CO;2-M","volume":"86","author":"Hughes","year":"1999","unstructured":"Hughes KS, Papa MZ, Whitney T, McLellan R (1999) Prophylactic Mastectomy and Inherited Predisposition to Breast Carcinoma. Cancer 86(11):2502\u20132516","journal-title":"Cancer"},{"key":"1100_CR42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1155\/1999\/605917","volume":"15","author":"Evans","year":"1998","unstructured":"Evans DGR, Anderson E, Lallo F et al. (1998) Utilisation of prophylactic mastectomy in 10 European centres. Dis Markers 15:148\u2013151","journal-title":"Dis Markers"},{"key":"1100_CR43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/ejso.1999.0756","volume":"26","author":"Al-Ghazal","year":"2000","unstructured":"Al-Ghazal SK, Blamey RW (2000) Subcutaneous mastectomy with implantat reconstruction: cosmetic outcome and patient satisfaction. Eur J Surg Oncol 26:137\u2013141","journal-title":"Eur J Surg Oncol"},{"key":"1100_CR44","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1470-2045(05)70210-2","volume":"6","author":"Metcalfe","year":"2005","unstructured":"Metcalfe KA, Semple JL, Narod SA (2005) Time to reconsider subcutaneous mastectomy for breast-cancer prevention? Lancet Oncol 6:431\u2013434","journal-title":"Lancet Oncol"},{"key":"1100_CR45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.1995.03520300065039","volume":"273","author":"NIH","year":"1995","unstructured":"NIH Consensus Development Panel on Ovarian Cancer (1995) NIH consensus conference. Ovarian cancer. Screening, treatment, and follow up. JAMA 273:491\u2013497","journal-title":"JAMA"},{"key":"1100_CR46","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(82)92681-2","volume":"2","author":"Tobacman","year":"1982","unstructured":"Tobacman JK, Greene MH, Tucker MA, Costa J, Kase R, Fraumeni JF Jr (1982) Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families. Lancet 2(8302):795\u2013797","journal-title":"Lancet"},{"key":"1100_CR47","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1002\/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J","volume":"71","author":"Piver","year":"1993","unstructured":"Piver SM, Jishi MF, Tsukada Y, Nava G (1993) Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. Cancer 71:2751\u20132755","journal-title":"Cancer"},{"key":"1100_CR48","first-page":"33","volume":"17","author":"Struewing","year":"1999","unstructured":"Struewing JP, Watson P, Easton DF, Ponder BA (1999) Prophylactic oophorectomy in inherited breast\/ ovarian cancer families. Monogr Natl Cancer Inst 17:33\u201335","journal-title":"Monogr Natl Cancer Inst"},{"key":"1100_CR49","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","volume":"346","author":"Kauff","year":"2002","unstructured":"Kauff ND, Satagopan JM, Robson ME et al. (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609\u20131615","journal-title":"N Engl J Med"},{"key":"1100_CR50","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","volume":"346","author":"Rebbeck","year":"2002","unstructured":"Rebbeck TR, Lynch HT, Neuhausen SL et al. (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616\u20131622","journal-title":"N Engl J Med"},{"key":"1100_CR51","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1200\/JCO.2000.18.14.2728","volume":"18","author":"Lu","year":"2000","unstructured":"Lu KH, Garber JE, Cramer DW et al. (2000) Occult Ovarian Tumors in Women With BRCA1 or BRCA2 Mutations Undergoing Prophylactic Oophorectomy. J Clin Oncol 18(14):2728\u20132732","journal-title":"J Clin Oncol"},{"key":"1100_CR52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","volume":"87","author":"Leeper","year":"2002","unstructured":"Leeper K, Garcia R, Swisher E, Goff B, Greer B, Paley P (2002) Pathologic Findings in Prophylactic Oophorectomy Specimens in High-Risk Women. Gynecol Oncol 87:52\u201356","journal-title":"Gynecol Oncol"},{"key":"1100_CR53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","volume":"23","author":"Powell","year":"2005","unstructured":"Powell CB, Kenley E, Chen LM et al. (2005) Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers: Role of Serial Sectioning in the Detection of Occult Malignancy. Journal of Clinical Oncology 23(1):127\u2013132","journal-title":"Journal of Clinical Oncology"},{"key":"1100_CR54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/01674829309084451","volume":"14","author":"Nathorst-Boos","year":"1993","unstructured":"Nathorst-Boos J, von Schoultz B, Carlstrom K (1993) Elective ovarian removel and estrogen replacement therapy: effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynecol 14:283\u2013293","journal-title":"J Psychosom Obstet Gynecol"},{"key":"1100_CR55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-2003-38433","volume":"63","author":"Beckmann","year":"2003","unstructured":"Beckmann MW, Braendle W, Brucker C et al. (2003) Konsensus-Empfehlung zur Hormontherapie (HT) im Klimakterium und in der Postmenopause. Im Auftrag des Vorstands der Deutschen Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe. Geburtsh Frauenheilk 63(3):209\u2013212","journal-title":"Geburtsh Frauenheilk"},{"key":"1100_CR56","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2003.09.052","volume":"21","author":"Meijers-Heijbouer","year":"2003","unstructured":"Meijers-Heijbouer H, Brekelmans CTM et al. (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21:1675\u20131681","journal-title":"J Clin Oncol"},{"key":"1100_CR57","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1200\/JCO.2002.20.5.1260","volume":"20","author":"Scheuer","year":"2002","unstructured":"Scheuer L, Kauff N, Robson M et al. (2002) Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers. J Clin Oncol 20(5):1260\u20131268","journal-title":"J Clin Oncol"},{"key":"1100_CR58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.20728","volume":"103","author":"Robson","year":"2005","unstructured":"Robson M, Svahn T, McCormick B, Borgen P, Hudis CA, Norton L, Offit K (2005) Appropriateness of Breast-Conserving Treatment of Breast Carcinoma in Women with Germline Mutations in BRCA1 or BRCA2. Cancer 103(1):44\u201351","journal-title":"Cancer"},{"key":"1100_CR59","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0140-6736(02)08434-9","volume":"359","author":"Haffty","year":"2002","unstructured":"Haffty BG, Harrold E, Khan AJ et al. (2002) Outcome of conservatively managed early-onset breast cancer by BRCA1\/BRCA2 status. Lancet 359:1471\u20131477","journal-title":"Lancet"},{"key":"1100_CR60","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/jnci\/93.22.1754","volume":"93","author":"Goffin","year":"2001","unstructured":"Goffin J, Chappuis P, Wong N, Foulkes WD (2001) Magnetic Response Imaging and Mammography in women with hereditary risk of breast cancer. J Natl Cancer Inst 93:1876\u20131881","journal-title":"J Natl Cancer Inst"},{"key":"1100_CR61","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","volume":"356","author":"Narod","year":"2000","unstructured":"Narod SA, Brunet JS, Ghadirian P et al. for the Hereditary Breast Cancer Clinical Study Group (2000) Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Lancet 356:1876\u20131881","journal-title":"Lancet"},{"key":"1100_CR62","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.10641","volume":"101","author":"M\u00f8ller","year":"2002","unstructured":"M\u00f8ller P, Borg \u01fa, Evans DG et al. (2002) Survival in prospectively ascertained familial Breast Cancer: Analysis of a Series stratified by Tumour Characteristics, BRCA Mutations and Oophoectomy. Int J Cancer 101:555\u2013559","journal-title":"Int J Cancer"},{"key":"1100_CR63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1075-122X.2004.21543.x","volume":"10","author":"Stolier","year":"2004","unstructured":"Stolier AJ, Fuhrmann GM, Mauterer L, Bolton JS, Superneau DW (2004) Initial experience with surgical treatment planing in the newly diagnosed breast cancer patient at high risk for BRCA1- or BRCA-2 Mutation. Breast J 10:475\u2013480","journal-title":"Breast J"},{"key":"1100_CR64","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archsurg.138.12.1323","volume":"138","author":"Weitzel","year":"2003","unstructured":"Weitzel JN, McCaffey SM, Nedelcu R, MacDonald DJ, Blazer KR, Culliname CA (2003) Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg 138:1323\u20131328","journal-title":"Arch Surg"},{"key":"1100_CR65","first-page":"65","volume":"2","author":"Lux","year":"2005","unstructured":"Lux MP (2005) BRCA1\/2 assoziiertes Mammakarzinom: BET oder Mastektomie? Senologie 2:65\u201366","journal-title":"Senologie"},{"key":"1100_CR66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.11048","volume":"97","author":"Adem","year":"2003","unstructured":"Adem C, Reynolds C, Soderberg CL et al. (2003) Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers. Cancer 97:1\u201311","journal-title":"Cancer"},{"key":"1100_CR67","unstructured":"Kiechle M, Schmutzler RK, Beckmann MW (2002) Pr\u00e4vention: Famili\u00e4res Mamma- und Ovarialkarzinom. Dtsch \u00c4rztebl 99(20):A-1372"},{"key":"1100_CR68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-9610(83)90188-5","volume":"145","author":"Humphrey","year":"1983","unstructured":"Humphrey LJ (1983) Subcutaneous mastectomy is not a prophylaxis against carcinoma of the breast: opinion or knowledge? Am J Surg 145:31\u2013312","journal-title":"Am J Surg"},{"key":"1100_CR69","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0025-6196(12)62008-4","volume":"61","author":"Woods","year":"1986","unstructured":"Woods JE (1986) Breast reconstruction: current state of the art. Mayo Clin Proc 61:579\u2013585","journal-title":"Mayo Clin Proc"},{"key":"1100_CR70","unstructured":"Bohmert HH (1988) Subcutaneous mastectomy. In: Grundfest-Broniatow-ski S, Esseltyn CB jr (eds) Controversies in Breast Disease: Diagnosis and Management. Marcel Dekker, New York, pp 235\u2013259"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-005-1100-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-005-1100-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-005-1100-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:15:58Z","timestamp":1558581358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-005-1100-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1007\/s00104-005-1100-4","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}